Representation of obesity in contemporary atrial fibrillation ablation randomized controlled trials.
Danielle DircksEh KhaingAhmad AroudakyMuaaz AlmerstaniNmair AlziadinRadha P KannegantiJames AgutoJmaylia MimmsChen-Yang JiangLluis MontDomenico GriecoCarina Blomstrom-LundqvistKarapet V DavtyanSandeep PrabhuPeter KistlerArash AryanaJason G AndradeLaurent MacleWilliam SchleiferJason PayneArthur EasleyFaris KhanJohn WindleShane TsaiDaniel AndersonGleb HaynatzkiThoetchai PeeraphatditNiyada NaksukPublished in: Journal of cardiovascular electrophysiology (2024)
Obesity is a common comorbidity among AF patients. However, most AF ablation RCTs underreported the proportion of participants with obesity and its impact on the primary outcomes.
Keyphrases
- atrial fibrillation
- insulin resistance
- metabolic syndrome
- weight loss
- catheter ablation
- high fat diet induced
- type diabetes
- end stage renal disease
- weight gain
- randomized controlled trial
- chronic kidney disease
- ejection fraction
- newly diagnosed
- left atrial
- peritoneal dialysis
- oral anticoagulants
- left atrial appendage
- direct oral anticoagulants
- radiofrequency ablation
- skeletal muscle
- coronary artery disease
- patient reported outcomes
- mitral valve
- systematic review
- acute coronary syndrome
- venous thromboembolism
- study protocol
- double blind